Citations

Citations to this article as recorded by  

• Deficient SARS-CoV-2 hybrid immunity during inflammatory bowel disease
  Amin Alirezaylavasani, Ingrid Marie Egner, Børresdatter Dahl, Adity Chopra, Taissa de Matos Kasahara, Guro Løvik Goll, Jørgen Jahnsen, Gunnveig Grødeland, John Torgils Vaage, Fridtjof Lund-Johansen, Jan Cato Holter, Bente Halvorsen, Kristin Kaasen Jørgens
  Clinical Immunology.2025; 271: 110404.     CrossRef
• Small Bowel Diverticulosis and COVID-19: Awareness Is the Key: A Case Series and Review of the Literature
  Petros Bangeas, Nikolaos Konstantinidis, Tania Chrisopoulou, Despoina Karatzia, Alexandros Giakoustidis, Vasileios Papadopoulos
  Medicina.2024; 60(2): 229.     CrossRef
• Exacerbated gastrointestinal symptoms and long COVID in IBD patients with SARS-CoV-2 infection: A multi-center study from taiwan
  Tsung-Yu Tsai, Jia-Feng Wu, Meng-Tzu Weng, Chiao-Hsiung Chuang, Tien-Yu Huang, Wei-Chen Tai, Chi-Ming Tai, Chen-Shuan Chung, Chih-Cheng Chen, Ching-Pin Lin, Yuan-Yao Tsai, Shu-Chen Wei
  Journal of the Formosan Medical Association.2024; 123(8): 866.     CrossRef
• COVID-19 IN INFLAMMATORY BOWEL DISEASE: SHOULD WE BE MORE CAREFUL WITH THE USE OF SALICYLATES?
  Mariana Rolim Fernandes MACEDO, Carlos Arthur Fernandes SOBREIRA, Carola Braz de LAVOR, Camila Ribeiro RÔLA, Ticiana Maria de Lavor ROLIM, Francisco Sérgio Rangel de Paula PESSOA, Milena Santana GIRÃO, Caio César Furtado FREIRE, Ranna Caroline Bezerra SIE
  Arquivos de Gastroenterologia.2024;[Epub]     CrossRef
• Impact of preexisting digestive problems on the gastrointestinal symptoms of patients with omicron variant of SARS-CoV-2 infection
  Xinghuang Liu, Bayasgalan Luvsandagva, Dongke Wang, Siran Zhu, Zhiyue Xu, Dan Zhou, Xiaotian Xie, Wei Qian, Xiaohua Hou, Tao Bai, Dong Keon Yon
  PLOS ONE.2024; 19(10): e0312545.     CrossRef
• Diarrhea and Coronavirus Disease 2019 Infection
  David M. Friedel, Mitchell S. Cappell
  Gastroenterology Clinics of North America.2023; 52(1): 59.     CrossRef
• Managing IBD in the COVID-19 era
  Nicholas Scalzo, Ryan C. Ungaro
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Impact of COVID-19 in individuals with and without pre-existent digestive disorders with a particular focus on elderly patients
  Alfredo Papa, Marcello Covino, Sara Sofia De Lucia, Angelo Del Gaudio, Marcello Fiorani, Giorgia Polito, Carlo Romano Settanni, Andrea Piccioni, Francesco Franceschi, Antonio Gasbarrini
  World Journal of Gastroenterology.2023; 29(26): 4099.     CrossRef
• Twelve Months with COVID-19: What Gastroenterologists Need to Know
  Giulia Concas, Michele Barone, Ruggiero Francavilla, Fernanda Cristofori, Vanessa Nadia Dargenio, Rossella Giorgio, Costantino Dargenio, Vassilios Fanos, Maria Antonietta Marcialis
  Digestive Diseases and Sciences.2022; 67(7): 2771.     CrossRef
• Perceptions and Behaviors of Patients with Inflammatory Bowel Disease during the COVID-19 Crisis
  Yoo Jin Lee, Kyeong Ok Kim, Min Cheol Kim, Kwang Bum Cho, Kyung Sik Park, Byeong Ik Jang
  Gut and Liver.2022; 16(1): 81.     CrossRef
• Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic
  Simeng Lin, Louis HS Lau, Neil Chanchlani, Nicholas A Kennedy, Siew C Ng
  Gut.2022; 71(7): 1426.     CrossRef
• Vaccination strategies for Korean patients with inflammatory bowel disease
  Yoo Jin Lee, Eun Soo Kim
  The Korean Journal of Internal Medicine.2022; 37(5): 920.     CrossRef
• Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements
  Yong Eun Park, Yoo Jin Lee, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seong-Eun Kim, Seung-Jae Myung
  Intestinal Research.2022; 20(4): 431.     CrossRef
• Endoscopy within 7 days after detecting high calprotectin levels can be useful for therapeutic decision-making in ulcerative colitis
  Ho Min Yong, Sung-Jo Park, Seong Ran Jeon, Heesu Park, Hyun Gun Kim, Tae Hee Lee, Junseok Park, Jin-Oh Kim, Joon Seong Lee, Bong Min Ko, Hyeon Jeong Goong, Suyeon Park
  Medicine.2021; 100(34): e27065.     CrossRef
• KASID Guidance for Clinical Practice Management of Adult Inflammatory Bowel Disease during the COVID-19 Pandemic: Expert Consensus Statement
  Yong Eun Park, Yoo Jin Lee, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seong-Eun Kim, Seung-Jae Myung
  The Korean Journal of Gastroenterology.2021; 78(2): 105.     CrossRef
• The natural history of COVID-19 in patients with inflammatory bowel disease: a nationwide study by the Hellenic Society for the study of IBD
  Giorgos Bamias, Georgios Kokkotis, Angeliki Christidou, Dimitrios K. Christodoulou, Vasileios Delis, Georgia Diamantopoulou, Smaragdi Fessatou, Anthia Gatopoulou, Olga Giouleme, Panagiota Kafritsa, Chrisostomos Kalantzis, Andreas Kapsoritakis, Pantelis Ka
  European Journal of Gastroenterology & Hepatology.2021; 33(1S): e810.     CrossRef

Citations

Citations to this article as recorded by  

• What should intensivists know about immune checkpoint inhibitors and their side effects?
  Viktor Yordanov Zlatkov Aleksandrov, Fernando Martínez Sagasti, Juncal Pérez-Somarriba Moreno, Helena Huertas Mondéjar
  Medicina Intensiva (English Edition).2025; : 502135.     CrossRef
• The association between metformin use, immune mediated colitis and overall survival in patients treated with checkpoint inhibitor
  Malek Shatila, Carolina Colli Cruz, Linfeng Lu, Kian Abdul-baki, Elliot Baerman, Kei Takigawa, Andres Urias Rivera, Irene Jeong-Ah Lee, Sean Ngo, Gabriel Sperling, Abdullah Sagar Aleem, Raakhi Menon, Andrew Sullivan, Varun Vemulapalli, Cristina Natha, Tan
  European Journal of Cancer.2025; 221: 115405.     CrossRef
• Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy
  Despoina Chrysostomou, Lauren A. Roberts, Julian R. Marchesi, James M. Kinross
  Gastroenterology.2023; 164(2): 198.     CrossRef
• Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease
  Seung Yong Shin, Young Kim, Won-Seok Kim, Jung Min Moon, Kang-Moon Lee, Sung-Ae Jung, Hyesook Park, Eun Young Huh, Byung Chang Kim, Soo Chan Lee, Chang Hwan Choi
  Intestinal Research.2023; 21(1): 148.     CrossRef
• Obesity Measured via Body Mass Index May Be Associated with Increased Incidence but Not Worse Outcomes of Immune-Mediated Diarrhea and Colitis
  Miho Kono, Malek Shatila, Guofan Xu, Yang Lu, Antony Mathew, Wasay Mohajir, Krishnavathana Varatharajalu, Wei Qiao, Anusha S. Thomas, Yinghong Wang
  Cancers.2023; 15(8): 2329.     CrossRef
• Gut microbiome homeostasis and the future of probiotics in cancer immunotherapy
  Ankita Singh, Sharon Grace Alexander, Sunil Martin
  Frontiers in Immunology.2023;[Epub]     CrossRef
• Gut Microbiome and Colorectal Cancer
  Tae-Geun Gweon
  The Korean Journal of Gastroenterology.2023; 82(2): 56.     CrossRef
• Impact ofHelicobacter pyloriinfection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors
  Patrick T Magahis, Steven B Maron, Darren Cowzer, Stephanie King, Mark Schattner, Yelena Janjigian, David Faleck, Monika Laszkowska
  Journal for ImmunoTherapy of Cancer.2023; 11(10): e007699.     CrossRef
• Comments on Efficacy of a Synbiotic Containing Lactobacillus paracasei DKGF1 and Opuntia humifusa in Elderly Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
  Kwang Woo Kim
  Gut and Liver.2023; 17(6): 954.     CrossRef
• MTA1 aggravates experimental colitis in mice by promoting transcription factor HIF1A and up-regulating AQP4 expression
  Ping Li, Dong-Ping Shi, Tao Jin, Dong Tang, Wei Wang, Liu-Hua Wang
  Cell Death Discovery.2022;[Epub]     CrossRef
• Crosstalk between mucosal microbiota, host gene expression, and sociomedical factors in the progression of colorectal cancer
  Namjoo Kim, Jeong-An Gim, Beom Jae Lee, Byung il Choi, Hee Sook Yoon, Seung Han Kim, Moon Kyung Joo, Jong-Jae Park, Chungyeul Kim
  Scientific Reports.2022;[Epub]     CrossRef
• Exploration of Potential Gut Microbiota-Derived Biomarkers to Predict the Success of Fecal Microbiota Transplantation in Ulcerative Colitis: A Prospective Cohort in Korea
  Gi-Ung Kang, Sowon Park, Yeongyun Jung, Jai J. Jee, Min-Sueng Kim, Seungjun Lee, Dong-Woo Lee, Jae-Ho Shin, Hong Koh
  Gut and Liver.2022; 16(5): 775.     CrossRef
• Physical Activity as the Best Supportive Care in Cancer: The Clinician’s and the Researcher’s Perspectives
  Cécile Torregrosa, Frédéric Chorin, Eva Ester Molina Beltran, Cindy Neuzillet, Victoire Cardot-Ruffino
  Cancers.2022; 14(21): 5402.     CrossRef
• Microbial Modulation in Inflammatory Bowel Diseases
  Jongwook Yu, Jae Hee Cheon
  Immune Network.2022;[Epub]     CrossRef
• Immune Checkpoint Inhibitor-Associated Colitis: From Mechanism to Management
  Liansha Tang, Jialing Wang, Nan Lin, Yuwen Zhou, Wenbo He, Jiyan Liu, Xuelei Ma
  Frontiers in Immunology.2021;[Epub]     CrossRef

Recent studies have identified sprue-like illness associated with the use of the antihypertensive agent olmesartan medoxomil. However, whether this condition is specific to the use of olmesartan or is associated with the use of drugs belonging to the class of “sartans” remains to be clarified. A 45-year-old woman with chronic kidney disease along with hypothyroidism and hypertension presented with chronic diarrhea and significant weight loss. Endoscopy of the upper gastrointestinal tract showed scalloping and grooving of the duodenum, and histopathological examination showed subtotal villous atrophy. She was on telmisartan for hypertension, which was discontinued. Subsequently, diarrhea ameliorated dramatically, and she regained weight. To our knowledge, this is the first study to report telmisartan-associated sprue-like enteropathy. Further, we have reviewed the cases of patients with sprue-like enteropathy caused by valsartan, irbesartan, and eprosartan.

Citations

Citations to this article as recorded by  

• Olmesartan induced gastritis and enteropathy
  Ankur Gupta, Priyanka Jain, Latika Gupta
  Indian Journal of Gastroenterology.2024; 43(3): 684.     CrossRef
• Systematic review: Clinical phenotypes, histopathological features and prognosis of enteropathy due to angiotensin II receptor blockers
  Annalisa Schiepatti, Paolo Minerba, Michele Puricelli, Stiliano Maimaris, Giovanni Arpa, Federico Biagi, David S. Sanders
  Alimentary Pharmacology & Therapeutics.2024; 59(4): 432.     CrossRef
• Olmesartan induced enteropathy affecting the entire gastrointestinal tract: a case report
  N Van Horebeek, R Croes, A Vonck, E Colpaert
  Acta Gastro Enterologica Belgica.2023; 86(1): 95.     CrossRef
• A Case of Sprue-like Enteropathy Associated With Valsartan and Irbesartan
  Seo Yeon Yoo, Jihun Kim, Kee Wook Jung
  Journal of Neurogastroenterology and Motility.2022; 28(2): 327.     CrossRef
• The histological spectrum of ARB‐induced gastritis
  Tanner Storozuk, Ian Brown, Stephen Lagana, Maria Westerhoff, Namrata Setia, John Hart, Lindsay Alpert
  Histopathology.2022; 81(5): 653.     CrossRef
• Severe cases of sprue‐like enteropathy associated with angiotensin receptor blockers other than olmesartan
  Peter Malfertheiner, Chiara Formigoni
  GastroHep.2021; 3(2): 88.     CrossRef
• Telmisartan-induced sprue-like enteropathy: a case report
  Natalia Alzueta, Amaya Echeverría, Lorea Sanz, Carmen Fontela, Teresa Acín, Lidia Montenegro, Javier Garjón
  European Journal of Hospital Pharmacy.2020; 27(1): 49.     CrossRef
• Olmesartan Associated Enteropathy: Usefulness of Video Capsule Endoscopy in a Case With Doubtful Upper Endoscopic/Histological Picture
  Francesco Abbruzzi, Ilaria Loconte, Sonia Carparelli, Enzo Ierardi, Alfredo Di Leo, Mariabeatrice Principi
  Current Drug Safety.2020; 15(1): 65.     CrossRef
• Traitement par olmésartan et entéropathie : à propos de deux cas et revue de la littérature
  A. Sadki, M. Le Besnerais, F. Héron, I. Marie
  La Revue de Médecine Interne.2019; 40(2): 112.     CrossRef
• A simple treatment for a potentially life-threatening cause of malabsorption
  Mattia Bonzi, Elisa M. Fiorelli, Gaia Montanelli, Ludovico Furlan, Monica Solbiati
  Internal and Emergency Medicine.2019; 14(6): 967.     CrossRef
• Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review
  Ayesha Kamal, Christopher Fain, Angela Park, Peiqi Wang, Eduardo Gonzalez-Velez, Daniel A Leffler, Susan M Hutfless
  Gastroenterology Report.2019; 7(3): 162.     CrossRef
• Association of sprue-like enteropathy and angiotensin receptor-1 antagonists
  René R. Wenzel, Christian Datz
  Wiener klinische Wochenschrift.2019; 131(19-20): 493.     CrossRef
• Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy
  Peter Malfertheiner, Claudio Ripellino, Nazarena Cataldo
  Pharmacoepidemiology and Drug Safety.2018; 27(6): 581.     CrossRef

As mast cells have been highlighted in the pathogenesis of diarrhea-predominant irritable bowel syndrome, a new term "mastocytic enterocolitis" was suggested by Jakate and colleagues to describe an increase in mucosal mast cells in patients with chronic intractable diarrhea and favorable response to treatment with antihistamines. Although it is not an established disease entity, two cases have been reported in the English medical literature. Here, for the first time in Asia, we report another case of chronic intractable diarrhea caused by gastrointestinal mastocytosis. The patient was a 70-year-old male with chronic intractable diarrhea for 3 months; the cause of the diarrhea remained obscure even after exhaustive evaluation. However, biopsy specimens from the jejunum were found to have increased mast cell infiltration, and the patient was successfully treated with antihistamines.

Citations

Citations to this article as recorded by  

• Mastocytic Enterocolitis: An Overlooked Diagnosis for Unexplained Chronic Diarrhea in a Patient With Colon Polyps and a Family History of Colon Cancer
  Leeann Hu, Liliana Franco, Jignesh Parikh, Vania Zayat
  Cureus.2023;[Epub]     CrossRef
• Systemic Mastocytosis: A Rare Cause of Diarrhea
  Leonard Hamera, Andrew M Santos, Sean-Patrick A Prince, Sreekanth Chandrupatla, Jeffrey Jordan
  Cureus.2020;[Epub]     CrossRef
• Gastrointestinal Manifestations of Hypereosinophilic Syndromes and Mast Cell Disorders: a Comprehensive Review
  Vivian C. Nanagas, Anna Kovalszki
  Clinical Reviews in Allergy & Immunology.2019; 57(2): 194.     CrossRef
• Mastocytosis
  Jingtao Chen, Patrick Brady, Jay Mamel
  The Nurse Practitioner.2019; 44(8): 17.     CrossRef
• The roles of mast cells in allergic inflammation and mast cell-related disorders
  Hee-Kyoo Kim
  Allergy, Asthma & Respiratory Disease.2017; 5(5): 248.     CrossRef

Chronic diarrhea is usually associated with a number of non-infectious causes. When definitive treatment is unavailable, symptomatic drug therapy is indicated. Pharmacologic agents for chronic diarrhea include loperamide, 5-hydroxytryptamine type 3 (5-HT₃) receptor antagonists, diosmectite, cholestyramine, probiotics, antispasmodics, rifaximin, and anti-inflammatory agents. Loperamide, a synthetic opiate agonist, decreases peristaltic activity and inhibits secretion, resulting in the reduction of fluid and electrolyte loss and an increase in stool consistency. Cholestyramine is a bile acid sequestrant that is generally considered as the first-line treatment for bile acid diarrhea. 5-HT₃ receptor antagonists have significant benefits in patients with irritable bowel syndrome (IBS) with diarrhea. Ramosetron improves stool consistency as well as global IBS symptoms. Probiotics may have a role in the prevention of antibiotic-associated diarrhea. However, data on the role of probiotics in the treatment of chronic diarrhea are lacking. Diosmectite, an absorbent, can be used for the treatment of chronic functional diarrhea, radiation-induced diarrhea, and chemotherapy-induced diarrhea. Antispasmodics including alverine citrate, mebeverine, otilonium bromide, and pinaverium bromide are used for relieving diarrheal symptoms and abdominal pain. Rifaximin can be effective for chronic diarrhea associated with IBS and small intestinal bacterial overgrowth. Budesonide is effective in both lymphocytic colitis and collagenous colitis. The efficacy of mesalazine in microscopic colitis is weak or remains uncertain. Considering their mechanisms of action, these agents should be prescribed properly.

Citations

Citations to this article as recorded by  

• Influence of gut bile acid composition on the glucose‐lowering effect and safety of metformin
  Deok Yong Yoon, Jungeun Kim, Joo‐Youn Cho, Jae‐Yong Chung
  British Journal of Clinical Pharmacology.2025; 91(4): 1208.     CrossRef
• Managing Irinotecan-Induced Diarrhea: A Comprehensive Review of Therapeutic Interventions in Cancer Treatment
  Xiaoqin Yang, Jiamei Chen, Yitao Wang, Yihan Wu, Jinming Zhang
  Pharmaceuticals.2025; 18(3): 359.     CrossRef
• Recent advances in montmorillonite-based composites for biomedical applications: A review
  Chong Xia, Jun Qian
  Journal of Drug Delivery Science and Technology.2025; 109: 107012.     CrossRef
• Racecadotril Versus Loperamide for Acute Diarrhea of Infectious Origin in Adults: A Systematic Review and Meta‐Analysis
  Maryam Aziz, Laiba Urooj Malik, Erum Javed, Syeda Zuha Sami, Muhammad Maaz, Muhammad Arham Khan, Muhammad Farmaan, Omer Farooq, Umer Iqbal, Aashish Kumar, Syed Ali Arsal, Shafin Bin Amin, Inibehe Ime Okon
  Health Science Reports.2025;[Epub]     CrossRef
• "Cholinergic side Effect-Free anticancer drugs: paving the way for safer and more effective cancer treatment"
  Ritu, Prakash Chandra, Asmita Das
  Journal of Biomolecular Structure and Dynamics.2024; 42(23): 13042.     CrossRef
• The role of gut microbiota in the development of salt-sensitive hypertension and the possible preventive effect of exercise
  Steven G. Chrysant
  Expert Review of Cardiovascular Therapy.2024; 22(6): 265.     CrossRef
• BIO ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CAPECITABINE AND DOCETAXEL AND ITS APPLICATION TO PHARMACOKINETIC STUDIES USING LC-MS/MS
  SHAIK NAGUL SHAREEF, K. V. PADMAVATHI, S. ARAVIND, MANNAM SUBBARAO
  International Journal of Applied Pharmaceutics.2024; : 275.     CrossRef
• Thermo sensitive and pH responsive surface modulated transdermal green tea nanogel: Structural, physiochemical and in vitro safety investigations
  Prashant Sahu, Sushil K. Kashaw, Shabaaz Begum JP, Mohammed Ghazwani, Yahya Alhamhoom, Umme Hani, Santosh Anand, Mohammad N. Alomary, Mohammad Azam Ansari
  Journal of Drug Delivery Science and Technology.2024; 102: 106382.     CrossRef
• Phase 1 dose escalation study of FGFR4 inhibitor in combination with pembrolizumab in advanced solid tumors patients
  Jianming Xu, Jiuwei Cui, Haiping Jiang, Yan Zeng, Xiuyu Cong
  Cancer Medicine.2023; 12(7): 7762.     CrossRef
• Efficacy of bile salt hydrolase synthesizing probiotic bacteria in the treatment of irritable bowel syndrome with diarrhea
  S.P. Polishchuk, A.V. Neverovskyi
  GASTROENTEROLOGY.2023; 57(2): 108.     CrossRef
• An Update on Herbal Products for the Management of Inflammatory Bowel Disease
  Himanshu Arya, Rameshwar Dass, Bhawna Chopra, Priyanka Kriplani, Geeta Deswal, Ajmer Singh Grewal, Ashwani K. Dhingra, Suresh Kumar
  Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry.2023; 22(1): 1.     CrossRef
• Human health implications of emerging diseases and the current situation in India's vaccine industry
  Jiban Kumar Behera, Pabitra Mishra, Anway Kumar Jena, Bhaskar Behera, Manojit Bhattacharya
  Science in One Health.2023; 2: 100046.     CrossRef
• Antidiarrheal Activities of the Methanol Leaf Extracts of Olinia rochetiana (Oliniaceae) Against Castor Oil-Induced Diarrhea in Mice
  Lidet Terefe, Aschalew Nardos, Asfaw Debella, Beyene Dereje, Melese Arega, Abiy Abebe, Worku Gemechu, Samuel Woldekidan
  Journal of Experimental Pharmacology.2023; Volume 15: 485.     CrossRef
• Shedding Light on Autophagy During Human Tuberculosis. A Long Way to Go
  Joaquin Miguel Pellegrini, Nancy Liliana Tateosian, María Paula Morelli, Verónica Edith García
  Frontiers in Cellular and Infection Microbiology.2022;[Epub]     CrossRef
• Olea europea L. Leaves and Hibiscus sabdariffa L. Petals Extracts: Herbal Mix from Cardiovascular Network Target to Gut Motility Dysfunction Application
  Laura Beatrice Mattioli, Maria Frosini, Rosa Amoroso, Cristina Maccallini, Elda Chiano, Rita Aldini, Francesco Urso, Ivan Corazza, Matteo Micucci, Roberta Budriesi
  Nutrients.2022; 14(3): 463.     CrossRef
• Antidiarrheal and Antisecretory Effect of 80% Hydromethanolic Leaf Extract of Moringa stenopetala Baker f. in Mice
  Menbere Getaneh Woldeyohannes, Gelila Tamyalew Eshete, Alfoalem Araba Abiye, Abebe Ejigu Hailu, Solomon Assefa Huluka, Wondmagegn Tamiru Tadesse, Saad Tayyab
  Biochemistry Research International.2022; 2022: 1.     CrossRef
• Kinetics of bactericidal potency with synergistic combination of allicin and selected antibiotics
  Souptik Bhattacharya, Pallavi Chakraborty, Dwaipayan Sen, Chiranjib Bhattacharjee
  Journal of Bioscience and Bioengineering.2022; 133(6): 567.     CrossRef
• Functional, Diagnostic and Therapeutic Aspects of Bile
  Monjur Ahmed
  Clinical and Experimental Gastroenterology.2022; Volume 15: 105.     CrossRef
• The Use of Traditional Chinese Medicine in Relieving EGFR-TKI-Associated Diarrhea Based on Network Pharmacology and Data Mining
  Shuaihang Hu, Wenchao Dan, Jinlei Liu, Peng Ha, Tong Zhou, Xinyuan Guo, Wei Hou, Akhilesh K. Tamrakar
  Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1.     CrossRef
• Autophagy Induction as a Host-Directed Therapeutic Strategy against Mycobacterium tuberculosis Infection
  Harresh Adikesavalu, Radha Gopalaswamy, Ashok Kumar, Uma Ranganathan, Sivakumar Shanmugam
  Medicina.2021; 57(6): 522.     CrossRef
• Evaluation of the Antidiarrheal and Antioxidant Effects of Some Chewing Sticks Commonly Used for Oral Hygiene in Ghana
  Edward Ken Essuman, Adjoa Agyemang Boakye, Clement Okraku Tettey, Gaston Hunkpe, Nii Korley Kortei, Henrietta Kwansa-Bentum, Sayanika Davi Waikhom, Enoch Aninagyei, Harish Chandra
  Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1.     CrossRef
• Scientific Evidence for the Treatment of Children with Irritable Bowel Syndrome
  Paolo Quitadamo, Sara Isoldi, Saverio Mallardo, Letizia Zenzeri, Giovanni Di Nardo
  Current Pediatric Reviews.2021; 17(2): 92.     CrossRef
• Immunotoxicity evaluation by subchronic oral administration of clothianidin in Sprague-Dawley rats
  Kanoko ONARU, Shuji OHNO, Shizuka KUBO, Satoki NAKANISHI, Tetsushi HIRANO, Youhei MANTANI, Toshifumi YOKOYAMA, Nobuhiko HOSHI
  Journal of Veterinary Medical Science.2020; 82(3): 360.     CrossRef
• Designing, structural determination and biological effects of rifaximin loaded chitosan- carboxymethyl chitosan nanogel
  Samah Attia Algharib, Ali Dawood, Kaixiang Zhou, Dongmei Chen, Chao Li, Kuiyu Meng, Muhammad Kashif Maa, Saeed Ahmed, Lingli Huang, Shuyu Xie
  Carbohydrate Polymers.2020; 248: 116782.     CrossRef
• A short course of oral ranitidine as a novel treatment for toddler’s diarrhea: a parallel-group randomized controlled trial
  Samuel N. Uwaezuoke, Ikenna K. Ndu, Chizoma I. Eneh, Chikere A. Anusiem, Adaeze C. Ayuk
  BMC Pediatrics.2020;[Epub]     CrossRef
• Future Oncotargets: Targeting Overexpressed Conserved Protein Targets in Androgen Independent Prostate Cancer Cell Lines
  Abdul M. Baig, Zohaib Rana, Mohammad M. Mannan, Areeba Khaleeq, Fizza Nazim, Preet Katyara, Farhat Abbas
  Anti-Cancer Agents in Medicinal Chemistry.2020; 20(8): 1017.     CrossRef
• Intestinal microorganisms involved in colorectal cancer complicated with dyslipidosis
  Shuwen Han, Yuefen Pan, Xi Yang, Miao Da, Qiang Wei, Yuhai Gao, Quan Qi, Lixin Ru
  Cancer Biology & Therapy.2019; 20(1): 81.     CrossRef
• Clinical practice of Chinese medicine navel therapy for chronic diarrhea: A literature review
  Meng‐rui Chen, Jiang Zhao, Shu‐fei Fu, Jia‐qi Yu, Xuan Zhang, Qi‐yang Zhang, Zhi‐huan Zhou
  Journal of Gastroenterology and Hepatology.2019; 34(4): 643.     CrossRef
• Efficacy and safety of pinaverium bromide combined with flupentixol-melitracen for diarrhea-type irritable bowel syndrome
  Lifeng Qin, Jinmei Qin, Qian Yang, Xiaoping Lv, Liyi Huang
  Medicine.2019; 98(2): e14064.     CrossRef
• Gut microbiome associated with chemotherapy-induced diarrhea from the CapeOX regimen as adjuvant chemotherapy in resected stage III colorectal cancer
  Zuo Fei, Yin Lijuan, Yang Xi, Wu Wei, Zhong Jing, Da Miao, Han Shuwen
  Gut Pathogens.2019;[Epub]     CrossRef
• Pathophysiology, Differential Diagnosis, and Treatment of Diabetic Diarrhea
  Alexandra Selby, Zachary Wilmer Reichenbach, Gregory Piech, Frank K. Friedenberg
  Digestive Diseases and Sciences.2019; 64(12): 3385.     CrossRef
• Identification of FDA-Approved Small Molecules Capable of Disrupting the Calmodulin–Adenylyl Cyclase 8 Interaction through Direct Binding to Calmodulin
  Michael P. Hayes, Monica Soto-Velasquez, C. Andrew Fowler, Val J. Watts, David L. Roman
  ACS Chemical Neuroscience.2018; 9(2): 346.     CrossRef
• Review article: an analysis of safety profiles of treatments for diarrhoea‐predominant irritable bowel syndrome
  Brian E. Lacy
  Alimentary Pharmacology & Therapeutics.2018; 48(8): 817.     CrossRef
• Chemotherapy Induced Diarrhea: A Case Report
  Jianing Hou, Chen Guo, Guan Li, Guoqing Lv
  Journal of Cancer Prevention & Current Research.2018;[Epub]     CrossRef
• Gut Microbiota in Health and Probiotics in Functional Bowel Disease
  Jai Hyun Rhyou
  The Ewha Medical Journal.2017; 40(1): 22.     CrossRef
• Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulation
  Franck F. Rahaghi, Jeremy P. Feldman, Roblee P. Allen, Victor Tapson, Zeenat Safdar, Vijay P. Balasubramanian, Shelley Shapiro, Michael A. Mathier, Jean M. Elwing, Murali M. Chakinala, R. James White
  Pulmonary Circulation.2017; 7(1): 167.     CrossRef
• Irinotecan-induced bile acid malabsorption is associated with down-regulation of ileal Asbt (Slc10a2) in mice
  A-xi Shi, Yan Zhou, Xiao-yi Zhang, Yan-shu Zhao, Hong-yan Qin, Yan-ping Wang, Xin-an Wu
  European Journal of Pharmaceutical Sciences.2017; 102: 220.     CrossRef
• Diarrhea in Multiple Myeloma: A Review of the Literature
  Beth Faiman
  Clinical Journal of Oncology Nursing.2016; 20(4): E100.     CrossRef
• Small Intestinal Infections
  Khushboo Munot, Donald P. Kotler
  Current Gastroenterology Reports.2016;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Prophylactic administration of overproducing-abscisic acid Bacillus licheniformis attenuated DSS-induced colitis in mice by regulating the gut microbiota and immune activity
  Zeyan Xu, Lijiang Zhao, Mengting Wu, Anqi Cui, Wei Chen, Guohao Zheng, Jingyi Zhou, Daqing Gao, Ruihua Shi
  BMC Microbiology.2025;[Epub]     CrossRef
• Common protein networks for various drug regimens of major depression are associated with complement and immunity
  Seungyeon Lee, Sora Mun, Jiyeong Lee, Hee-Gyoo Kang
  Journal of Psychopharmacology.2024; 38(9): 798.     CrossRef
• Baseline gut microbiome impacts probiotics Bacillus licheniformis CMCC63516 in modulating the gut microbiome and preventing antibiotic‐associated diarrhea: A double‐blind, randomized controlled trial
  Qian Zhou, Wenkui Dai, Yanmin Bao, Jing Chen, Xiaohua Han, Changshan Liu, Meijie Hou, Huisheng Yao, Changsuo Hao, Shuaicheng Li, Yuejie Zheng
  Clinical and Translational Medicine.2023;[Epub]     CrossRef
• Weizmannia coagulans: an Ideal Probiotic for Gut Health
  Shiqi Zhang, Pinglan Li, Suwon Lee, Yu Wang, Chunming Tan, Nan Shang
  Food Science and Human Wellness.2023; : 1.     CrossRef
• Bacillus licheniformis prevents and reduces anxiety-like and depression-like behaviours
  Siyuan Feng, Chen Meng, Yiyuan Liu, Yue Yi, Axin Liang, Yingyu Zhang, Zikai Hao
  Applied Microbiology and Biotechnology.2023; 107(13): 4355.     CrossRef
• Bacteremia caused by accidental injection of Bacillus licheniformis microbiota modulator through the central venous catheter
  Chuan Zhong, Fen Wang, Haining Zhou, Jiarui Liu, Jiewei Hu, Yongjun Chen
  Medicine.2022; 101(4): e28719.     CrossRef
• Bacillus licheniformis Reshapes the Gut Microbiota to Alleviate the Subhealth
  Siyuan Feng, Chen Meng, Zikai Hao, Hong Liu
  Nutrients.2022; 14(8): 1642.     CrossRef
• The effect of multispecies probiotics on cognitive reactivity to sad mood in patients with Crohn’s disease
  Lipei Wu, Fujun Shen, Weiwei Wang, Chunrun Qi, Chunbin Wang, Anquan Shang, Shihai Xuan
  Journal of Functional Foods.2021; 82: 104431.     CrossRef
• Bacillus licheniformis Zhengchangsheng® Inhibits Obesity by Regulating the AMP-Activated Protein Kinase Signaling Pathway
  Xiaojie Lu, Yue Jing, Xiaofei Zhou, Naisheng Zhang, Jiandong Tai, Yongguo Cao
  Probiotics and Antimicrobial Proteins.2021; 13(6): 1658.     CrossRef
• Oral Supplements of Combined Bacillus licheniformis Zhengchangsheng® and Xylooligosaccharides Improve High‐Fat Diet‐Induced Obesity and Modulate the Gut Microbiota in Rats
  Yuyuan Li, Man Liu, He Liu, Xiaoqing Wei, Xianying Su, Ming Li, Jieli Yuan, Zongbao K. Zhao
  BioMed Research International.2020;[Epub]     CrossRef
• Bacillus licheniformis Zhengchangsheng® attenuates DSS-induced colitis and modulates the gut microbiota in mice
  Y. Li, M. Liu, J. Zhou, B. Hou, X. Su, Z. Liu, J. Yuan, M. Li
  Beneficial Microbes.2019; 10(5): 543.     CrossRef
• Broad Prebiotic Potential of Non-starch Polysaccharides from Oats (Avena sativa L.): an in vitro Study
  VANDA SARGAUTIENE, ILVA NAKURTE, VIZMA NIKOLAJEVA
  Polish Journal of Microbiology.2018; 67(3): 307.     CrossRef
• Effect of Bacillus subtilis C-3102 on loose stools in healthy volunteers
  M. Hatanaka, K. Yamamoto, N. Suzuki, S. Iio, T. Takara, H. Morita, T. Takimoto, T. Nakamura
  Beneficial Microbes.2018; 9(3): 357.     CrossRef
• Rapid and simple detection of endospore counts in probiotic Bacillus cultures using dipicolinic acid (DPA) as a marker
  Xiao-Sheng Liang, Chun Liu, Zhu Long, Xiao-Hua Guo
  AMB Express.2018;[Epub]     CrossRef
• Gut Microbiota in Health and Probiotics in Functional Bowel Disease
  Jai Hyun Rhyou
  The Ewha Medical Journal.2017; 40(1): 22.     CrossRef
• Separation and determination of peptide metabolite of Bacillus licheniformis in a microbial fuel cell by high-speed capillary micellar electrokinetic chromatography
  Wei Wang, Ruiguang Bai, Xiaoyu Cai, Ping Lin, Lihong Ma
  Journal of Separation Science.2017; 40(22): 4446.     CrossRef
• Evaluation of chitosan hydrochloride-alginate as enteric micro-probiotic-carrier with dual protective barriers
  Qing-Xi Wu, Xin Xu, Qiu Xie, Wang-Yu Tong, Yan Chen
  International Journal of Biological Macromolecules.2016; 93: 665.     CrossRef